Table 1 Characteristics of the study population
From: Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients
ID | Age | Sex | Comorbidities | CT scan | rRT-PCR | Time to death | Ante-mortem organ failure | Treatments | Cause of death |
|---|---|---|---|---|---|---|---|---|---|
1 | 77 | M | CAD CVD Diabetes | NEG | POS | 3 | ARDS AKI | Mechanical ventilation Antibiotics | Cardiogenic shock MOF |
2 | 91 | F | Hypertension CAD CRF Liver cirrhosis | NEG | POS | 15 | ARDS AKI Hypoxic hepatitis | Hydroxychloroquine Antibiotics Corticosteroids | Respiratory failure |
3 | 68 | M | COPD Cancer | GGO | POS | 15 | ARDS AKI | Mechanical ventilation Hydroxychloroquine Lopinavir/Ritonavir Antibiotics | Respiratory failure |
4 | 64 | F | Hypertension Cancer CVD | MA | POS | 8 | ARDS | Mechanical ventilation Hydroxychloroquine Antibiotics | Respiratory failure |
5 | 56 | M | COPD Cancer | GGO | POS | 14 | ARDS AKI Hypoxic hepatitis | Mechanical ventilation ECMO RRT Hydroxychloroquine Lopinavir/Ritonavir Antibiotics | Mesenteric ischemia MOF |
6 | 73 | M | Hypertension CRF | BC | POS | 11 | ARDS AKI | Mechanical ventilation ECMO Hydroxychloroquine Remdesivir Corticosteroids Antiobiotics | Respiratory failure |
7 | 56 | M | None | BC | POS | 7 | ARDS AKI Hypoxic hepatitis | Hydroxychloroquine Antibiotics | Respiratory failure |
8 | 66 | M | Hypertension CAD CVD CRF Diabetes | Emphysema | POS | 14 | AKI | Antibiotics | Septic shock MOF |
9 | 49 | F | Hypertension Diabetes | GGO | POS | 17 | ARDS AKI | Mechanical ventilation RRT Hydroxychloroquine Lopinavir/Ritonavir Antibiotics | Respiratory failure |
10 | 63 | M | Hypertension Diabetes | GGO BC | POS | 16 | ARDS AKI | Mechanical ventilation ECMO RRT Hydroxychloroquine Oseltamivir Antibiotics | Respiratory failure |
11 | 76 | M | Diabetes Liver cirrhosis Cancer Diabetes | BC | POS | 5 | ARDS | Hydroxychloroquine Antibiotics | Sudden death |
12 | 75 | M | Hypertension CAD Diabetes | GGO | POS | 6 | ARDS AKI Hypoxic hepatitis | Mechanical ventilation Hydroxychloroquine Antibiotics | MOF |
13 | 73 | M | Diabetes | GGO BC | POS | 10 | ARDS | Hydroxychloroquine | Respiratory failure |
14 | 77 | F | Hypertension Diabetes | GGO BC | POS | 9 | ARDS AKI Hypoxic hepatitis | Hydroxychloroquine Antibiotics | Respiratory failure |
15 | 61 | M | GGO LP | POS | 31 | ARDS AKI Pulmonary embolism | Mechanical ventilation RRT Hydroxychloroquine Remdesivir Antibiotics | Septic shock MOF | |
16 | 70 | F | Hypertension Diabetes Liver transplant | GGOBC | POS | 19 | ARDS AKI Pulmonary embolism | Mechanical ventilation RRT Hydroxychloroquine Antibiotics | Septic shock MOF |
17 | 53 | M | Hypertension CVD | GGO BC LP | POS | 13 | ARDS AKI Pulmonary embolism | Mechanical ventilation ECMO RRT Hydroxychloroquine Antibiotics | Septic shock MOF |